Global Anti-Hypertensive Drugs Market

Key Highlights of the Report

• The worldwide antihypertensive drugs market is projected to attain sales of USD 28,475.16 million with the aid of 2030, with a compound annual growth fee (CAGR) of 3.29% from 2023 to 2030.
• The United States is the main market for antihypertensive capsules, accounting for over 25% proportion in 2022. This can be attributed to the high incidence of high blood pressure inside the U.S and the provision of superior healthcare infrastructure.
• THE Angiotensin II Receptor Blockers (ARBs) segment held over 20% in 2022. ARBs are widely prescribed because of their efficacy in lowering blood strain and comparatively favorable aspect impact profile.
• Retail pharmacies are the essential distribution channel for antihypertensive pills, accounting for over 25%. This is generally due to their accessibility and convenience for sufferers.

Executive Summary

The executive precisely outlines the antihypertensive tablets marketplace, highlighting the important findings and tremendous market trends. It consists of a precise of the marketplace size, growth fee, leading marketplace segments, distribution channels, and nearby analysis. Additionally, it briefly discusses the drivers, restraints, and opportunities influencing the marketplace.

Market Insights

The marketplace insights segment presents an in-depth understanding of the worldwide antihypertensive tablets market, such as marketplace dynamics, traits, and demanding situations. It features a comprehensive analysis of marketplace drivers, restraints, and possibilities that shape the growth and prospects of the market.

Current Market Trends inside the Antihypertensive Drugs Market

The international antihypertensive capsules market has witnessed a large increase in recent years. Antihypertensive capsules are medicines used to deal with excessive blood stress, also called hypertension. Hypertension is a persistent circumstance that impacts a massive population worldwide and is a leading motive of cardiovascular sicknesses.

Here are some of the present-day marketplace tendencies within the antihypertensive capsules marketplace:

Increasing Prevalence of Hypertension:

Hypertension has become a global health challenge, with a rising occurrence amongst each developed and growing international location. Factors together with sedentary existence, dangerous dietary behavior, weight problems, and stress contribute to the developing incidence of hypertension. As a result, the demand for antihypertensive capsules is increasing to manage and manage high blood pressure.

Growing Aging Population:

The world’s population is growing older swiftly, mainly in developed countries. With advancing age, the chance of developing hypertension will increase notably. As a result, the growing older populace is a key driving force in the antihypertensive tablets marketplace. The elderly population calls for non-stop scientific intervention and medicine to manage their blood strain degrees, creating a steady demand for antihypertensive capsules.

Technological Advancements in Drug Delivery Systems:

The pharmaceutical industry is witnessing fast advancements in drug delivery systems, undoubtedly impacting the antihypertensive capsules market. Novel drug delivery strategies, transdermal patches, microneedles, and implantable gadgets offer increased convenience, better efficacy, and reduced facet consequences. These advancements are probably to drive the adoption of antihypertensive tablets among sufferers.

Combination Therapies:

Combination treatment plans concerning a couple of antihypertensive drugs are gaining traction within the market. These treatment options offer synergistic effects and extra efficacy in controlling blood stress stages.

Combination treatment plans assist patients in obtaining their target blood strain more successfully and reduce the danger of hypertension-related complications. Pharmaceutical companies are investing in growing fixed-dose aggregate pills to fulfill the evolving remedy desires of patients.

Increased Focus on Precision Medicine:

Precision medicinal drug is a rising method that tailors clinical treatment to a person’s genetic makeup, way of life, and environmental factors. In hypertension, precision medicine holds promise for figuring out precise genetic markers and targeting personalized treatments.

Genomics and molecular biology advances are using the development of precision remedy-based antihypertensive cures, which are expected to revolutionize the marketplace.

Rising Awareness and Screening Programs:

Governments, healthcare organizations, and pharmaceutical corporations are mission projects to elevate focus approximately high blood pressure and promote normal blood pressure screenings. Increased consciousness about the effects of out-of-control high blood pressure and the provision of effective antihypertensive tablets are riding on more people seeking early prognosis and remedy. This heightened consciousness is contributing to the boom of the antihypertensive capsules marketplace.

Expansion in Emerging Markets:

Emerging economies, inclusive of China, India, and Brazil, provide substantial increase possibilities for the antihypertensive capsules market. These nations have large populations, growing healthcare fees, and high blood pressure cases. Moreover, authorities’ tasks to enhance healthcare infrastructure and remedy get admission to boost the marketplace growth in these regions.

Key Players and Competitive Landscape in the Antihypertensive Drugs Market

The antihypertensive capsules market is surprisingly competitive and fragmented, with numerous global key players. These groups invest closely in studies and improvement activities to introduce modern remedies and maintain market function. Here are some of the key gamers in the antihypertensive pills market:

1.      Pfizer Inc.:

Pfizer is a leading pharmaceutical business enterprise and one of the key gamers inside the antihypertensive pills marketplace. The company offers antihypertensive medications, such as amlodipine, lisinopril, and enalapril. Pfizer focuses on developing progressive drug formulations and investing in clinical trials to extend its product portfolio and cater to numerous affected persons’ desires.

2.      Novartis International AG:

Novartis is a global healthcare organization that manufactures and markets various antihypertensive capsules. The company’s portfolio includes popular manufacturers, including Diovan, Exforge, and Co-Diovan. Novartis invests closely in studies and improvement to discover new therapeutic options and improve patient consequences.

3.      AstraZeneca PLC:

AstraZeneca is a multinational pharmaceutical employer with a widespread antihypertensive drug market presence. The corporation gives medicines like Atacand and Inderal to manage high blood pressure. AstraZeneca focuses on strategic collaborations and acquisitions to reinforce its product pipeline and increase its market proportion.

4.      Merck & Co., Inc.:

Merck, called MSD Outdoor in the U.S. and Canada, is a main pharmaceutical organization developing antihypertensive tablets. The company’s portfolio includes famous manufacturers along with Cozaar and Hyzaar. Merck invests in medical research and collaborations with healthcare vendors to increase the remedy of hypertension.

5.      Boehringer Ingelheim GmbH:

Boehringer Ingelheim is a studies-driven pharmaceutical company supplying numerous antihypertensive tablets, which include Micardis and Twynsta. The enterprise makes a specialty of innovation and invests in novel healing procedures and drug transport systems to beautify patient adherence and remedy outcomes.

6.      Sanofi S.A.:

Sanofi is a global healthcare agency with a diverse product portfolio that includes antihypertensive medicinal drugs like Lovenox and Avapro. The organization emphasizes studies and improvement to expand subsequent-era antihypertensive drugs and maintain its aggressive area inside the marketplace.

7.      Daiichi Sankyo Company, Limited:

Daiichi Sankyo is a Japanese pharmaceutical employer developing and marketing antihypertensive tablets with Benicar and Azor. The employer strives to increase innovative cures and leverage strategic partnerships to cope with unmet scientific desires in hypertension control.

The antihypertensive capsules market is also characterized using the presence of conventional drug producers, contributing to marketplace competition and affordability. Some prominent commonplace gamers encompass Teva Pharmaceutical Industries Ltd., Mylan N.V., and Lupin Limited.

The antihypertensive tablets marketplace is witnessing numerous trends, including the increasing occurrence of hypertension, technological advancements in drug transport systems, and the point of interest in precision remedies.

Key players within the marketplace, such as Pfizer, Novartis, and AstraZeneca, are investing in research and improvement sports to introduce innovative therapies and keep an aggressive facet. As the call for antihypertensive capsules continues to thrust upward, the market is predicted to develop and broaden in the coming years.

Market Overview

The marketplace overview segment offers a detailed analysis of the antihypertensive tablets market, including its definition, class, and scope. It overviews the marketplace structure, key stakeholders, and regulatory landscape, along with highlighting the market segmentation based totally on drug magnificence, distribution channel, and region.

Market Drivers

Increasing Prevalence of Hypertension

Hypertension, or high blood pressure, is a large international health subject. The growing occurrence of high blood pressure, specifically some of the growing old populace, is a primary driving force for the antihypertensive capsules marketplace. Sedentary lifestyles, unhealthy nutritional behavior, and genetic predisposition contribute to the developing incidence of high blood pressure.

Advancements in Drug Development

The continuous improvements in drug development have led to introducing of revolutionary and more effective antihypertensive pills. These consist of novel drug classes, mixture treatments, and focused treatments that provide higher blood strain control and advanced patient effects. The availability of various antihypertensive capsules with various movement mechanisms has multiplied treatment alternatives for healthcare specialists.

Growing Awareness and Diagnosis

Increasing awareness approximately the risks related to hypertension and the importance of blood stress control has led to higher diagnosis fees. Individuals are more likely to seek scientific interest and cling to prescribed antihypertensive drug regimens.

Additionally, healthcare providers are actively concerned with screening and early detection applications, leading to early intervention and stepped-forward management of high blood pressure.

Favorable Government Initiatives

Governments and international healthcare companies have applied diverse initiatives to combat the weight of high blood pressure. These projects have consciousness of public recognition campaigns, preventive measures, and advanced get admission to healthcare services. Government guidance in coverage reforms, funding, and reimbursement schemes for antihypertensive capsules has undoubtedly inspired a market boom.

Market Restraints

Adverse Effects and Safety Concerns

Despite the efficacy of antihypertensive pills, some medications are related to adverse consequences that may affect the affected person’s compliance and ordinary remedy effects. Common consequences include dizziness, fatigue, dry cough, erectile dysfunction, and electrolyte imbalances. Safety worries related to lengthy-time period use, drug interactions, and contraindications also can deter patients from adhering to medicine regimens.

Non-Adherence to Medication

Non-adherence to prescribed antihypertensive drug regimens remains a sizable challenge in dealing with hypertension. Factors such as forgetfulness, complicated drug regimens, price of medicinal drugs, and absence of perceived symptoms contribute to bad remedy adherence. Non-adherence can lead to uncontrolled blood strain and an improved hazard of cardiovascular complications.

Market Opportunities

Rising Demand for Combination Therapies

Combination remedies, which involve using or greater antihypertensive pills with complementary mechanisms of movement, are gaining recognition. Compared to high-dose monotherapies, these remedies provide synergistic results, progressive blood strain manipulation, and reduced aspect outcomes. The increasing call for aggregate remedies allows pharmaceutical corporations to expand innovative fixed-dose mixture merchandise.

Technological Advancements in Drug Delivery

Technological improvements in drug delivery structures can doubtlessly beautify the efficacy and convenience of antihypertensive drug management. Novel drug transport methods, including transdermal patches, implantable gadgets, and controlled-launch formulations, can improve patient compliance and reduce dosing frequency. These improvements offer opportunities for pharmaceutical agencies to broaden affected person-friendly formulations.

Competitive Landscape

The global antihypertensive pills market is pretty aggressive, with numerous pharmaceutical groups striving to benefit a larger market proportion. Key gamers within the market consist of Novartis AG, Pfizer Inc., Merck & Co., Inc., Sanofi S.A., and AstraZeneca PLC, among others.

These businesses invest heavily in research and improvement sports to introduce revolutionary and efficacious antihypertensive pills.

Future Outlook

The destiny outlook for the global antihypertensive drugs marketplace appears promising, driven by several factors, the developing prevalence of hypertension, growing healthcare expenditure, and advancements in drug improvement.

Rising Prevalence of Hypertension:

The global burden of high blood pressure continues to grow due to lifestyle modifications, getting old populations, and the superiority of danger elements of weight problems and sedentary lifestyles. This ongoing trend is expected to pressure the call for antihypertensive drugs.

Technological Advancements:

Advances in pharmaceutical studies and development, consisting of precision medicine and centered healing procedures, are anticipated to revolutionize the high blood pressure remedy. Novel drug transport systems, consisting of transdermal patches and inhalation gadgets, provide stepped-forward comfort and patient compliance.

Focus on Combination Therapies:

Combination cures regarding more than one antihypertensive pill with distinctive mechanisms of motion are gaining popularity. These treatment plans provide more advantageous efficacy, convenience, and fee effectiveness. Pharmaceutical corporations will probably invest in developing and advertising mixture capsules to cater to this growing demand.

Increasing Generic Competition:

The patent expiration of numerous blockbuster antihypertensive tablets has opened the marketplace to generic opposition. Generic versions of famous pills, including losartan and amlodipine, have gained a widespread market percentage because of their cost-effectiveness. This trend is expected to continue, driving market competition and decreasing general drug costs.

Focus on Emerging Markets:

Pharmaceutical organizations are increasingly focused on emerging markets, including Asia Pacific and Latin America, due to the high occurrence of hypertension in these areas. Companies are investing in product localization, strategic partnerships, and regulatory compliance to tap into those growing markets.

Patient-Centric Approach:

There is a developing emphasis on patient-centric healthcare specializing in personalized remedy options and affected person schooling. This approach empowers sufferers to participate in remedies actively and cling to prescribed medicines. Pharmaceutical organizations will likely spend money on virtual fitness technology and patient help programs to enhance remedy effects.

Why Buy This Report

This complete report on the antihypertensive pills marketplace gives valuable insights into the enterprise, presenting an in-depth analysis of market tendencies, drivers, restraints, possibilities, and competitive panorama. By purchasing this report, you’ll benefit get admission to the following advantages:

• The report presents a radical analysis of the worldwide antihypertensive pills marketplace, such as marketplace size, boom fee, and destiny projections.
• It highlights the current market developments within the antihypertensive tablets market and helps you perceive rewarding opportunities and stay ahead of the opposition.
• The report offers a segmented aggressive panorama, supplying an overview of key antihypertensive drug market gamers.
•  It comprehensively evaluates the antihypertensive capsules market across key areas, together with North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
• The report discusses the regulatory landscape governing the antihypertensive capsules marketplace, such as key policies, approvals, and hints.
• The report offers strategic tips for market players and stakeholders based on the comprehensive analysis of the antihypertensive tablets market.
• It affords a destiny outlook for antihypertensive tablets, highlighting the key factors riding market boom and development.

CHAPTER NO. 1 : INTRODUCTION 12

1.1. Report Description 12

1.1.1. Purpose of the Report 12

1.1.2. USP & Key Offerings 12

1.2. Key Benefits for Stakeholders 12

1.3. Target Audience 13

1.4. Report Scope 13

CHAPTER NO. 2 : EXECUTIVE SUMMARY 16

2.1. Antihypertensive Drugs Market Snapshot 16

2.2. Global Antihypertensive Drugs Market, 2017 – 2030  (USD Million) 18

2.1. Insights from Primary Respondents 18

CHAPTER NO. 3 : COVID 19 IMPACT ANALYSIS 19

3.1. Impact Assessment of COVID-19 Pandemic, By Region 19

CHAPTER NO. 4 : ANTIHYPERTENSIVE DRUGS MARKET – INDUSTRY ANALYSIS 20

4.1. Introduction 20

4.2. Market Drivers 21

4.2.1. Increasing prevalence of hypertension 21

4.2.2. Growing awareness and diagnosis 22

4.3. Market Restraints 22

4.3.1. Restraining Factor Analysis 22

4.4. Market Opportunities 23

4.4.1. Market Opportunity Analysis 23

4.5. Porter’s Five Forces Analysis 23

4.6. Value Chain Analysis 24

CHAPTER NO. 5 : KEY INVESTMENT POCKETS ANALYSIS 25

5.1. Top Investment Pockets 25

5.1.1.1. Antihypertensive Drugs Market Attractiveness Analysis, By Drug Class 25

5.1.1.2. Antihypertensive Drugs Market Attractiveness Analysis, By Distribution Channel 25

5.2. Product Life Cycle Analysis 26

5.3. Incremental Revenue Growth Opportunity, 2023 – 2030 27

5.3.1. Drug Class 27

5.3.2. Distribution Channel 27

CHAPTER NO. 6 : IMPORT EXPORT ANALYSIS 28

6.1. Import Analysis by Region 28

6.1.1. Global Antihypertensive Drugs Market Import Volume, By Region, 2017 – 2022 (USD Million) 28

6.2. Export Analysis by Region 28

6.2.1. Global Antihypertensive Drugs Market Export Volume, By Region, 2017 – 2022 (USD Million) 28

CHAPTER NO. 7 : DEMAND SUPPLY ANALYSIS 29

7.1. Demand Analysis by Region 29

7.1.1. Global Antihypertensive Drugs Market Demand Volume, By Region, 2017 – 2022 (USD Million) 29

7.2. Supply Analysis by Region 29

7.2.1. Global Antihypertensive Drugs Market Supply Volume, By Region, 2017 – 2022 (USD Million) 29

CHAPTER NO. 8 : MARKET POSITIONING OF KEY PLAYERS 30

8.1. Company Market Share Analysis –2020 and 2022 30

8.1.1. Global Antihypertensive Drugs Market: Company Market Share, 2022 30

8.1.2. Global Antihypertensive Drugs Market: Company Market Share, 2022 30

8.1. Global Antihypertensive Drugs Market Company Volume Market Share, 2022 31

8.2. Global Antihypertensive Drugs Market Company Revenue Market Share, 2022 32

8.3. Market Position of Key Players 2022 33

8.3.1. Market Position of Key Players, 2022 33

8.4. Strategic Developments 34

8.4.1. Acquisitions & Mergers 34

8.4.2. New Product Launch 34

8.4.3. Regional Expansion 34

CHAPTER NO. 9 : ANTIHYPERTENSIVE DRUGS MARKET – BY DRUG CLASS SEGMENT ANALYSIS 35

9.1. Antihypertensive Drugs Market Overview, by Drug Class Segment 35

9.1.1. Global Antihypertensive Drugs Market Revenue Share, By Drug Class, 2022 & 2030 36

9.2. Diuretics 37

9.2.1. Global Diuretics Antihypertensive Drugs Market Revenue, By Region, 2017 – 2022 (USD Million) 37

9.3. Beta-blockers 38

9.3.1. Global Diuretics Antihypertensive Drugs Market Revenue, By Region, 2017 – 2022 (USD Million) 38

9.4. ACE inhibitors 39

9.4.1. Global ACE inhibitors Antihypertensive Drugs Market Revenue, By Region, 2017 – 2022 (USD Million) 39

9.5. ARBs 40

9.5.1. Global ARBs Antihypertensive Drugs Market Revenue, By Region, 2017 – 2022 (USD Million) 40

9.6. Calcium channel blockers & Renin inhibitors 41

9.6.1. Global Calcium channel blockers & Renin inhibitors Antihypertensive Drugs Market Revenue, By Region, 2017 – 2022 (USD Million) 41

CHAPTER NO. 10 : ANTIHYPERTENSIVE DRUGS MARKET – BY DISTRIBUTION CHANNEL SEGMENT ANALYSIS 42

10.1. Antihypertensive Drugs Market Overview, by Distribution Channel Segment 42

10.1.1. Global Antihypertensive Drugs Market Revenue Share, By Distribution Channel, 2022 & 2030 43

10.2. Hospital pharmacies 44

10.2.1. Global Antihypertensive Drugs for Hospital pharmacies Market Revenue, By Region, 2017 – 2022 (USD Million) 44

10.3. Retail pharmacies 45

10.3.1. Global Antihypertensive Drugs for Retail pharmacies Market Revenue, By Region, 2017 – 2022 (USD Million) 45

10.4. Online pharmacies 46

10.4.1. Global Antihypertensive Drugs for Online pharmacies Market Revenue, By Region, 2017 – 2022 (USD Million) 46

10.5. Others 47

10.5.1. Global Antihypertensive Drugs for Others Market Revenue, By Region, 2017 – 2022 (USD Million) 47

CHAPTER NO. 11 : ANTIHYPERTENSIVE DRUGS MARKET – REGIONAL ANALYSIS 49

11.1. Antihypertensive Drugs Market Overview, by Region Segment 49

11.1.1. Global Antihypertensive Drugs Market Revenue Share, By Region, 2022 & 2030 50

11.1.2. Global Antihypertensive Drugs Market Revenue, By Region, 2017 – 2022 (USD Million) 51

11.1.3. Global Antihypertensive Drugs Market Revenue, By Drug Class, 2017 – 2022 (USD Million) 52

11.1.4. Global Antihypertensive Drugs Market Revenue, By Distribution Channel, 2017 – 2022 (USD Million) 53

11.2. North America 54

11.2.1. North America Antihypertensive Drugs Market Revenue, By Country, 2017 – 2022 (USD Million) 55

11.2.2. North America Antihypertensive Drugs Market Revenue, By Drug Class, 2017 – 2022 (USD Million) 56

11.2.3. North America Antihypertensive Drugs Market Revenue, By Distribution Channel, 2017 – 2022 (USD Million) 57

11.2.4. U.S. 58

11.2.5. Canada 58

11.2.6. Mexico 58

11.3. Europe 59

11.3.1. Europe Antihypertensive Drugs Market Revenue, By Country, 2017 – 2022 (USD Million) 60

11.3.2. Europe Antihypertensive Drugs Market Revenue, By Drug Class, 2017 – 2022 (USD Million) 61

11.3.3. Europe Antihypertensive Drugs Market Revenue, By Distribution Channel, 2017 – 2022 (USD Million) 62

11.3.4. UK 63

11.3.5. France 63

11.3.6. Germany 63

11.3.7. Italy 63

11.3.8. Spain 63

11.3.9. Russia 63

11.3.10. BENELUX 63

11.3.11. Sweden 63

11.3.12. Denmark 63

11.3.13. Poland 63

11.3.14. Austria 63

11.3.15. Rest of Europe 63

11.4. Asia Pacific 64

11.4.1. Asia Pacific Antihypertensive Drugs Market Revenue, By Country, 2017 – 2022 (USD Million) 65

11.4.2. Asia Pacific Antihypertensive Drugs Market Revenue, By Drug Class, 2017 – 2022 (USD Million) 66

11.4.3. Asia Pacific Antihypertensive Drugs Market Revenue, By Distribution Channel, 2017 – 2022 (USD Million) 67

11.4.4. China 68

11.4.5. Japan 68

11.4.6. South Korea 68

11.4.7. India 68

11.4.8. Thailand 68

11.4.9. Indonesia 68

11.4.10. Vietnam 68

11.4.11. Malaysia 68

11.4.12. Philippines 68

11.4.13. Taiwan 68

11.4.14. Rest of Asia Pacific 68

11.5. Latin America 69

11.5.1. Latin America Antihypertensive Drugs Market Revenue, By Country, 2017 – 2022 (USD Million) 70

11.5.2. Latin America Antihypertensive Drugs Market Revenue, By Drug Class, 2017 – 2022 (USD Million) 71

11.5.3. Latin America Antihypertensive Drugs Market Revenue, By Distribution Channel, 2017 – 2022 (USD Million) 72

11.5.4. Brazil 73

11.5.5. Argentina 73

11.5.6. Colombia 73

11.5.7. Chile 73

11.5.8. Peru 73

11.5.9. Rest of Latin America 73

11.6. The Middle-East 74

11.6.1. Middle East Antihypertensive Drugs Market Revenue, By Country, 2017 – 2022 (USD Million) 75

11.6.2. Middle East Antihypertensive Drugs Market Revenue, By Drug Class, 2017 – 2022 (USD Million) 76

11.6.3. Middle East Antihypertensive Drugs Market Revenue, By Distribution Channel, 2017 – 2022 (USD Million) 77

11.6.4. GCC Countries 78

11.6.5. Israel 78

11.6.6. Turkey 78

11.6.7. Iran 78

11.6.8. Rest of Middle East & Africa 78

11.7. Africa 79

11.7.1. Africa Antihypertensive Drugs Market Revenue, By Country, 2017 – 2022 (USD Million) 80

11.7.2. Africa Antihypertensive Drugs Market Revenue, By Drug Class, 2017 – 2022 (USD Million) 81

11.7.3. Africa Antihypertensive Drugs Market Revenue, By Distribution Channel, 2017 – 2022 (USD Million) 82

11.7.4. South Africa 83

11.7.5. Egypt 83

11.7.6. Nigeria 83

11.7.7. Algeria 83

11.7.8. Morocco 83

11.7.9. Rest of Africa 83

CHAPTER NO. 12 : COMPANY PROFILES 84

12.1. Novartis International AG 84

12.1.1. Company Overview 84

12.1.2. Product Portfolio 84

12.1.3. Financial Overview 84

12.2. Pfizer Inc 85

12.3. Merck & Co., Inc. 85

12.4. AstraZeneca PLC 85

12.5. Daiichi Sankyo Company, Limited 85

12.6. Boehringer Ingelheim International GmbH 85

12.7. Sanofi S.A. 85

12.8. Johnson & Johnson Services, Inc. 85

12.9. Takeda Pharmaceutical Company Limited 85

12.10. Bristol-Myers Squibb Company 85

12.11. Company 11 85

12.12. Company 12 85

12.13. Company 13 85

12.14. Company 14 85

CHAPTER NO. 13 : RESEARCH METHODOLOGY 86

13.1. Research Methodology 86

13.2. Phase I – Secondary Research 87

13.3. Phase II – Data Modeling 87

13.3.1. Company Share Analysis Model 88

13.3.2. Revenue Based Modeling 88

13.4. Phase III – Primary Research 89

13.5. Research Limitations 90

13.5.1. Assumptions 90

List of Figures

FIG NO. 1. Global Antihypertensive Drugs Market Volume & Revenue, 2017 – 2030  (USD Million) 18

FIG NO. 2. Porter’s Five Forces Analysis for Global Antihypertensive Drugs Market 23

FIG NO. 3. Value Chain Analysis for Global Antihypertensive Drugs Market 24

FIG NO. 4. Market Attractiveness Analysis, By Drug Class 25

FIG NO. 5. Market Attractiveness Analysis, By Distribution Channel 25

FIG NO. 6. Product Life Cycle Analysis 26

FIG NO. 7. Incremental Revenue Growth Opportunity by Drug Class 27

FIG NO. 8. Incremental Revenue Growth Opportunity by Distribution Channel 27

FIG NO. 9. Company Share Analysis, 2020 30

FIG NO. 10. Company Share Analysis, 2022 30

FIG NO. 11. Antihypertensive Drugs Market – Company Volume  Market Share, 2022 31

FIG NO. 12. Antihypertensive Drugs Market – Company Revenue Market Share, 2022 32

FIG NO. 13. Market Position of Key Players, 2022 33

FIG NO. 14. Global Antihypertensive Drugs Market Revenue Share, By Drug Class, 2022 & 2030 36

FIG NO. 15. Global Antihypertensive Drugs Market for Diuretics, Volume & Revenue  (USD Million) 2017 – 2030 37

FIG NO. 16. Global Antihypertensive Drugs Market for Beta-blockers, Volume & Revenue  (USD Million) 2017 – 2030 38

FIG NO. 17. Global Antihypertensive Drugs Market for ACE inhibitors, Volume & Revenue  (USD Million) 2017 – 2030 39

FIG NO. 18. Global Antihypertensive Drugs Market for ARBs, Volume & Revenue  (USD Million) 2017 – 2030 40

FIG NO. 19. Global Antihypertensive Drugs Market for Calcium channel blockers & Renin inhibitors, Volume & Revenue  (USD Million) 2017 – 2030 41

FIG NO. 20. Global Antihypertensive Drugs Market Revenue Share, By Distribution Channel, 2022 & 2030 43

FIG NO. 21. Global Antihypertensive Drugs Market for Hospital pharmacies, Volume & Revenue  (USD Million) 2017 – 2030 44

FIG NO. 22. Global Antihypertensive Drugs Market for Retail pharmacies, Volume & Revenue  (USD Million) 2017 – 2030 45

FIG NO. 23. Global Antihypertensive Drugs Market for Online pharmacies, Volume & Revenue  (USD Million) 2017 – 2030 46

FIG NO. 24. Global Antihypertensive Drugs Market for Others, Volume & Revenue  (USD Million) 2017 – 2030 47

FIG NO. 25. Global Antihypertensive Drugs Market for Distribution Channel 5, Volume & Revenue  (USD Million) 2017 – 2030 48

FIG NO. 26. Global Antihypertensive Drugs Market Revenue Share, By Region, 2022 & 2030 50

FIG NO. 27. North America Antihypertensive Drugs Market Volume & Revenue, 2017 – 2022  (USD Million) 54

FIG NO. 28. Europe Antihypertensive Drugs Market Volume & Revenue, 2017 – 2022  (USD Million) 59

FIG NO. 29. Asia Pacific Antihypertensive Drugs Market Volume & Revenue, 2017 – 2022  (USD Million) 64

FIG NO. 30. Latin America Antihypertensive Drugs Market Volume & Revenue, 2017 – 2022  (USD Million) 69

FIG NO. 31. The Middle-East Antihypertensive Drugs Market Volume & Revenue, 2017 – 2022  (USD Million) 74

FIG NO. 32. Africa Antihypertensive Drugs Market Volume & Revenue, 2017 – 2022  (USD Million) 79

FIG NO. 33. Research Methodology – Detailed View 86

FIG NO. 34. Research Methodology 87

List of Tables

TABLE NO. 1. : Global Antihypertensive Drugs Market: Snapshot 16

TABLE NO. 2. : Drivers for the Antihypertensive Drugs Market: Impact Analysis 21

TABLE NO. 3. : Restraints for the Antihypertensive Drugs Market: Impact Analysis 22

TABLE NO. 4. : Global Antihypertensive Drugs Market Import Volume, By End-user, 2017 – 2022 (USD Million) 28

TABLE NO. 5. : Global Antihypertensive Drugs Market Export Volume, By End-user, 2017 – 2022 (USD Million) 28

TABLE NO. 6. : Global Antihypertensive Drugs Market Demand Volume, By End-user, 2017 – 2022 (USD Million) 29

TABLE NO. 7. : Global Antihypertensive Drugs Market Supply Volume, By End-user, 2017 – 2022 (USD Million) 29

TABLE NO. 8. : Global Diuretics Antihypertensive Drugs Market Revenue, By Region, 2017 – 2022 (USD Million) 37

TABLE NO. 9. : Global Diuretics Antihypertensive Drugs Market Revenue, By Region, 2023– 2030 (USD Million) 37

TABLE NO. 10. : Global Diuretics Antihypertensive Drugs Market Revenue, By Region, 2017 – 2022 (USD Million) 38

TABLE NO. 11. : Global Diuretics Antihypertensive Drugs Market Revenue, By Region, 2023– 2030 (USD Million) 38

TABLE NO. 12. : Global ACE inhibitors Antihypertensive Drugs Market Revenue, By Region, 2017 – 2022 (USD Million) 39

TABLE NO. 13. : Global ACE inhibitors Antihypertensive Drugs Market Revenue, By Region, 2023– 2030 (USD Million) 39

TABLE NO. 14. : Global ARBs Antihypertensive Drugs Market Revenue, By Region, 2017 – 2022 (USD Million) 40

TABLE NO. 15. : Global ARBs Antihypertensive Drugs Market Revenue, By Region, 2023– 2030 (USD Million) 40

TABLE NO. 16. : Global Calcium channel blockers & Renin inhibitors Antihypertensive Drugs Market Revenue, By Region, 2017 – 2022 (USD Million) 41

TABLE NO. 17. : Global Calcium channel blockers & Renin inhibitors Antihypertensive Drugs Market Revenue, By Region, 2023– 2030 (USD Million) 41

TABLE NO. 18. : Global Antihypertensive Drugs for Hospital pharmacies Market Revenue, By Region, 2017 – 2022 (USD Million) 44

TABLE NO. 19. : Global Antihypertensive Drugs for Hospital pharmacies Market Revenue, By Region, 2023– 2030 (USD Million) 44

TABLE NO. 20. : Global Antihypertensive Drugs for Retail pharmacies Market Revenue, By Region, 2017 – 2022 (USD Million) 45

TABLE NO. 21. : Global Antihypertensive Drugs for Retail pharmacies Market Revenue, By Region, 2023– 2030 (USD Million) 45

TABLE NO. 22. : Global Antihypertensive Drugs for Online pharmacies Market Revenue, By Region, 2017 – 2022 (USD Million) 46

TABLE NO. 23. : Global Antihypertensive Drugs for Online pharmacies Market Revenue, By Region, 2023– 2030 (USD Million) 46

TABLE NO. 24. : Global Antihypertensive Drugs for Others Market Revenue, By Region, 2017 – 2022 (USD Million) 47

TABLE NO. 25. : Global Antihypertensive Drugs for Others Market Revenue, By Region, 2023– 2030 (USD Million) 47

TABLE NO. 26. : Global Antihypertensive Drugs for Distribution Channel 5 Market Revenue, By Region, 2017 – 2022 (USD Million) 48

TABLE NO. 27. : Global Antihypertensive Drugs for Distribution Channel 5 Market Revenue, By Region, 2023– 2030 (USD Million) 48

TABLE NO. 28. : Global Antihypertensive Drugs Market Revenue, By Region, 2017 – 2022 (USD Million) 51

TABLE NO. 29. : Global Antihypertensive Drugs Market Revenue, By Region, 2023– 2030 (USD Million) 51

TABLE NO. 30. : Global Antihypertensive Drugs Market Revenue, By Drug Class, 2017 – 2022 (USD Million) 52

TABLE NO. 31. : Global Antihypertensive Drugs Market Revenue, By Drug Class, 2023– 2030 (USD Million) 52

TABLE NO. 32. : Global Antihypertensive Drugs Market Revenue, By Distribution Channel, 2017 – 2022 (USD Million) 53

TABLE NO. 33. : Global Antihypertensive Drugs Market Revenue, By Distribution Channel, 2023– 2030 (USD Million) 53

TABLE NO. 34. : North America Antihypertensive Drugs Market Revenue, By Country, 2017 – 2022 (USD Million) 55

TABLE NO. 35. : North America Antihypertensive Drugs Market Revenue, By Country, 2023– 2030 (USD Million) 55

TABLE NO. 36. : North America Antihypertensive Drugs Market Revenue, By Drug Class, 2017 – 2022 (USD Million) 56

TABLE NO. 37. : North America Antihypertensive Drugs Market Revenue, By Drug Class, 2023– 2030 (USD Million) 56

TABLE NO. 38. : North America Antihypertensive Drugs Market Revenue, By Distribution Channel, 2017 – 2022 (USD Million) 57

TABLE NO. 39. : North America Antihypertensive Drugs Market Revenue, By Distribution Channel, 2023– 2030 (USD Million) 57

TABLE NO. 40. : Europe Antihypertensive Drugs Market Revenue, By Country, 2017 – 2022 (USD Million) 60

TABLE NO. 41. : Europe Antihypertensive Drugs Market Revenue, By Country, 2023– 2030 (USD Million) 60

TABLE NO. 42. : Europe Antihypertensive Drugs Market Revenue, By Drug Class, 2017 – 2022 (USD Million) 61

TABLE NO. 43. : Europe Antihypertensive Drugs Market Revenue, By Drug Class, 2023– 2030 (USD Million) 61

TABLE NO. 44. : Europe Antihypertensive Drugs Market Revenue, By Distribution Channel, 2017 – 2022 (USD Million) 62

TABLE NO. 45. : Europe Antihypertensive Drugs Market Revenue, By Distribution Channel, 2023– 2030 (USD Million) 62

TABLE NO. 46. : Asia Pacific Antihypertensive Drugs Market Revenue, By Country, 2017 – 2022 (USD Million) 65

TABLE NO. 47. : Asia Pacific Antihypertensive Drugs Market Revenue, By Country, 2023– 2030 (USD Million) 65

TABLE NO. 48. : Asia Pacific Antihypertensive Drugs Market Revenue, By Drug Class, 2017 – 2022 (USD Million) 66

TABLE NO. 49. : Asia Pacific Antihypertensive Drugs Market Revenue, By Drug Class, 2023– 2030 (USD Million) 66

TABLE NO. 50. : Asia Pacific Antihypertensive Drugs Market Revenue, By Distribution Channel, 2017 – 2022 (USD Million) 67

TABLE NO. 51. : Asia Pacific Antihypertensive Drugs Market Revenue, By Distribution Channel, 2023– 2030 (USD Million) 67

TABLE NO. 52. : Latin America Antihypertensive Drugs Market Revenue, By Country, 2017 – 2022 (USD Million) 70

TABLE NO. 53. : Latin America Antihypertensive Drugs Market Revenue, By Country, 2023– 2030 (USD Million) 70

TABLE NO. 54. : Latin America Antihypertensive Drugs Market Revenue, By Drug Class, 2017 – 2022 (USD Million) 71

TABLE NO. 55. : Latin America Antihypertensive Drugs Market Revenue, By Drug Class, 2023– 2030 (USD Million) 71

TABLE NO. 56. : Latin America Antihypertensive Drugs Market Revenue, By Distribution Channel, 2017 – 2022 (USD Million) 72

TABLE NO. 57. : Latin America Antihypertensive Drugs Market Revenue, By Distribution Channel, 2023– 2030 (USD Million) 72

TABLE NO. 58. : Middle East Antihypertensive Drugs Market Revenue, By Country, 2017 – 2022 (USD Million) 75

TABLE NO. 59. : Middle East Antihypertensive Drugs Market Revenue, By Country, 2023– 2030 (USD Million) 75

TABLE NO. 60. : Middle East Antihypertensive Drugs Market Revenue, By Drug Class, 2017 – 2022 (USD Million) 76

TABLE NO. 61. : Middle East Antihypertensive Drugs Market Revenue, By Drug Class, 2023– 2030 (USD Million) 76

TABLE NO. 62. : Middle East Antihypertensive Drugs Market Revenue, By Distribution Channel, 2017 – 2022 (USD Million) 77

TABLE NO. 63. : Middle East Antihypertensive Drugs Market Revenue, By Distribution Channel, 2023– 2030 (USD Million) 77

TABLE NO. 64. : Africa Antihypertensive Drugs Market Revenue, By Country, 2017 – 2022 (USD Million) 80

TABLE NO. 65. : Africa Antihypertensive Drugs Market Revenue, By Country, 2023– 2030 (USD Million) 80

TABLE NO. 66. : Africa Antihypertensive Drugs Market Revenue, By Drug Class, 2017 – 2022 (USD Million) 81

TABLE NO. 67. : Africa Antihypertensive Drugs Market Revenue, By Drug Class, 2023– 2030 (USD Million) 81

TABLE NO. 68. : Africa Antihypertensive Drugs Market Revenue, By Distribution Channel, 2017 – 2022 (USD Million) 82

TABLE NO. 69. : Africa Antihypertensive Drugs Market Revenue, By Distribution Channel, 2023– 2030 (USD Million) 82